Ignite Creation Date:
2025-12-24 @ 11:09 PM
Ignite Modification Date:
2026-03-03 @ 9:15 PM
Study NCT ID:
NCT00914069
Status:
TERMINATED
Last Update Posted:
2017-04-13
First Post:
2009-06-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
Sponsor:
C. R. Bard
Organization:
Study Overview
Official Title:
Evaluation of the Safety and Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter for Peripheral Intravenous (PIV) Insertion in Children, Oncology Patients and Elderly: a Controlled Randomized Trial
Status:
TERMINATED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Funding Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will test a hypothesis that the RIVS system will have a higher rate of successful first PIV placement compared to conventional catheter without a significant increase in complications and time of procedure.
Detailed Description:
The hypothesis to be statistically tested was that the RIVS system will have a higher rate of successful first attempt peripheral intravenous placement success as compared to conventional peripheral intravenous catheters without a significant increase in device related complications and procedure time.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: